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ABSTRACT Although the highly conservedCa21/calmodulin-dependent protein kinase II (CaMKII) is known to play an essential
role in cardiacmyocytes, its involvement in the frequency-dependent acceleration of relaxation is still controversial. To investigate
the functional signiﬁcance ofCaMKII autophosphorylation and its regulation by protein phosphatases (PPs) in heart, we developed
a new mathematical model for the CaMKIId isoform. Due to better availability of experimental data, the model was ﬁrst adjusted
to the kinetics of the neuronal CaMKIIa isoform and then converted to a CaMKIIdmodel by ﬁtting to kinetic data of the d isoform.
Both models satisfactorily reproduced experimental data of the CaMKII-calmodulin interaction, the autophosphorylation rate, and
the frequency dependence of activation. The level of autophosphorylated CaMKII cumulatively increased upon starting the Ca21
stimulation at 3 Hz in the d model. Variations in PP concentration remarkably affected the frequency-dependent activation of
CaMKIId, suggesting that cellular PP activity plays a key role in adjustingCaMKII activation in heart. The inhibitory effect of PPwas
stronger for CaMKIIa compared to CaMKIId. Simulation results revealed a potential involvement of CaMKIId autophosphorylation
in the frequency-dependent acceleration of relaxation at physiological heart rates and PP concentrations.
INTRODUCTION
With increasing heart rate, myocardial relaxation is accelerated
to allow appropriate reﬁlling of the ventricular cavity with the
venous return (1,2). The Ca21/calmodulin-dependent protein
kinase II (CaMKII) has been implicated in this autoregulation
of frequency-dependent acceleration of relaxation (FDAR) (3–
5). CaMKII is activated through the binding of Ca21-bound
calmodulin (CaM) during the transient increase in the intra-
cellular Ca21 concentration ([Ca21]i). In cardiac myocytes,
activated CaMKII molecules phosphorylate many intracellular
target proteins, including major components involved in exci-
tation-contraction coupling (6,7), such as the sarcolemmal
L-type Ca21 channel, the ryanodine receptor, and the Ca21
pump on the sarcoplasmic reticulum. With a rise in the fre-
quency of the Ca21 transient, the lifetime of activated CaMKII
molecules is increased by intersubunit autophosphorylation,
leading to an accumulation of the active CaMKII. Phosphor-
ylated CaMKII maintains its catalytic activity even after the
Ca21 transient until it is inactivated by constitutive phosphatase
activity. This was shown ﬁrst for the brain-speciﬁc a and b
isoforms of CaMKII and implicated in long-term potentiation,
a mechanism playing a role in memory and learning (8,9).
In heart, the predominant CaMKII isoform d is found in
two splice variants, dB localized to the nucleus and dC to the
cytoplasm (10). Both variants were shown to undergo auto-
phosphorylation (11). Autophosphorylation of CaMKII could
potentiate the action of CaMKII during cyclic Ca21 transients
and thereby help to decode the stimulation frequency (12).
However, the role of CaMKII and its autophosphorylation in
the FDAR is still not well understood and is a subject of con-
troversy (3,5,13,14). Furthermore, it has not yet been examined
quantitatively how CaMKII activity is regulated by changes in
heart rate.
Several computer models simulating CaMKII function have
been developed based on in vitro experimental data, with the
majority focusing on the neuronal CaMKII a and b isoforms
(15–19). Although simple models for studying CaMKII ac-
tivity in cardiac myocytes have been proposed, they are not
directly based on experimental data on the d isoform (20,21),
nor do they consider deactivation of CaMKII by protein
phosphatases (PPs) (22). It was experimentally demonstrated
that the d isoform has a higher afﬁnity for CaM (Kd¼ 33.5 nM)
compared to a (Kd ¼ 62.4 nM) and a higher autophosphor-
ylation rate, suggesting functional differences among the iso-
forms (22). Here, we introduce a novel CaMKII model that
reﬂects the molecular properties of the d isoform. This model
achieves a good accordance with experimental data in vitro.
The roles of CaMKII autophosphorylation and dephosphory-
lation by PPs in the frequency-dependent activation of CaMKII
were demonstrated employing a cardiac Ca21 transient model.
METHOD
Model structure
The CaMKII holoenzyme is a macromolecular complex consisting of two
stacked ring-shaped hexamers. Binding of fully Ca21-bound CaM (CaMCa4)
to the autoinhibitory domain of CaMKII exposes the catalytic site, which is
capable of phosphorylating a wide range of target proteins. In addition, an
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activated CaMKII subunit is able to autophosphorylate neighboring subunits
of the holoenzyme at Thr287. A phosphorylated CaMKII subunit has a 1000-
fold higher afﬁnity for CaMCa4 than a nonphosphorylated one. Furthermore,
in the phosphorylated state, CaMKII shows partial activity even after dis-
sociation of CaMCa4. CaMKII is completely deactivated only after de-
phosphorylation by PPs (9).
CaM, a highly conserved protein, possesses at its C-terminal lobe two
high-afﬁnity Ca21-binding sites with a Kd of;1–2 mM and at its N-terminal
lobe two low-afﬁnity sites with a Kd of ;2.6–13 mM, depending on ex-
perimental conditions (12,23,24). Since dissociation of Ca21 from the
C-terminal lobe is slow, the fraction of C- and N-terminal lobes occupied
with Ca21 might increase with increasing frequency of the Ca21 transient.
This mechanism may play an essential role in the activation of CaMKII.
Therefore, we used the sequential four-step Ca21 binding model described
by Holmes (16) (CaM, CaMCa, CaMCa2, CaMCa3, CaMCa4) (Fig. 1 A).
This model includes cooperative Ca21 binding within each lobe and assumes
that the C-terminal Ca21 binding sites are occupied before the N-terminal
sites. The time-dependent changes of individual CaM states are determined
as shown below:
CA1 ¼ k1½Ca21 ½CaM1 k1½CaMCa (1)
CA2 ¼ k2½Ca21 ½CaMCa1 k2½CaMCa2 (2)
CA3 ¼ k3½Ca21 ½CaMCa21 k3½CaMCa3 (3)
CA4 ¼ k4½Ca21 ½CaMCa31 k4½CaMCa4 (4)
d½CaMCa=dt ¼ CA11CA2 (5)
d½CaMCa2=dt ¼ CA21CA3 (6)
d½CaMCa3=dt ¼ CA31CA4 (7)
d½CaMCa4=dt ¼ CA4 (8)
½CaM ¼ ½CaMtotal  ½CaMCa
 ½CaMCa2  ½CaMCa3  ½CaMCa4: (9)
A [CaM]total of 6 mMwas used as reported for cardiac myocytes (12). Values
for the rate constants (k1, k1, k2, k2, k3, k3, k4, and k4) were adapted from
the original model (16), but adjusted to account for a temperature change
from 25C to 37C (multiplied by 2.5; Table 1). The Hill coefﬁcient (nH) and
K0.5 for the [Ca
21]-CaMCa4 relationship are 1.9 and 26 mM, respectively.
This relationship is slightly different from that measured in a-toxin perme-
abilized cells, which resulted in nH ¼ 2.6 and Kd ¼ 1 mM (25). It should be
noted that an accurate measurement of free [CaMCa4] in vivo is difﬁcult, since
about half of the CaMmolecules are membrane bound and probably clustered
(27) and many proteins compete for free CaMCa4 molecules (25,28).
A four-state CaMKII model was developed, as shown in Fig. 1 B, with
a nonactive state (CaMKII) and three active states, a CaMCa4-bound
state (CaMKII_CaMCa4), an autophosphorylated CaMCa4-bound state
(CaMKIIP_CaMCa4), and an autophosphorylated CaMCa4-dissociated state
(CaMKIIP). All active states are assumed to have the same activity. The rate
A1 for the binding of CaMCa4 to CaMKII is calculated with an association
rate constant k_asso as follows:
Al ¼ k asso3 ½CaMKII½CaMCa4: (10)
For dissociation of CaMCa4 from the CaMKII_CaMCa4 complex (rate A2 in
Fig. 1 B), two pathways are assumed: In pathway 1, CaMCa4 dissociates
from CaMKII_CaMCa4 with a rate constant k_disso. In pathway 2, Ca
21
dissociates before separation of the CaMKII_CaMCa4 complex with a
lumped rate constant k_dissoCa, which was determined by model ﬁtting to
be about one order faster than k_disso (Table 1). For the dissociation of Ca21
from CaMKII_CaMCa4, a Kd value (KmCaM) is used as reported from
experimental data (23). Assuming an instantaneous dissociation of Ca21
from CaMKII_CaMCa4, step A2 is described as follows:











The autophosphorylation of a CaMKII subunit is an intersubunit reaction
within the same hexamer ring, with each subunit reacting only with
neighboring subunits (9,29). For a given subunit, the probability (P) that
either or both sides of a neighboring subunit are active is described by Eq. 12
using the probability that both sides are inactive.
P ¼ 1 ½CaMKII=½CaMKIItotal
 2
: (12)
Then the phosphorylation rate B1 from CaMKII_CaMCa4 to CaMKIIP_
CaMCa4 is given as
B1 ¼ kcat3P ½ATP½ATP1KmATP½CaMKII CaMCa4; (13)
where kcat is the rate constant, and KmATP is the Michaelis constant for the
CaMKII-ATP complex.
Autophosphorylated CaMKII is dephosphorylated by several types of PPs
(30,31), and 90% of PP activity in mammalian heart is mediated by PP1 and
PP2A (32,33). Recently, PP1 was reported to dephosphorylate CaMKII in
intact rat cardiac myocytes (14). In this study, only PP1 is considered. The
dephosphorylation from CaMKIIP_CaMCa4 to CaMKII_CaMCa4 (Fig. 1 B,
rate B2) is deﬁned based on Michaelis-Menten kinetics, as shown below:
FIGURE 1 (A) Scheme of a CaM model (see Eqs. 1–9 for kinetic
dynamics). (B) Scheme of a CaMKII model (see Eqs. 10–21 for kinetic
dynamics). This model consists of one inactive state (CaMKII) and three
active states (CaMKII_CaMCa4 (CaMCa4 bound to CaMKII); CaMKIIP_
CaMCa4 (phosphorylated CaMKII_CaMCa4); and CaMKIIP (CaMCa4
dissociated from phosphorylated CaMKII dissociated from CaMCa4)).
For dissociation of CaMCa4 from CaMKII_CaMCa4 (A2) or CaMKIIP_
CaMCa4 (C1), two pathways are assumed, as indicated by numerals 1 and 2,
respectively.
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B2 ¼ kcat PP1 ½CaMKIIP CaMCa4½CaMKIIP CaMCa41Km PP1½PP1:
(14)
Similarly, rate D1 for the dephosphorylation from CaMKIIP to CaMKII is
calculated as
D1 ¼ kcat PP1 ½CaMKIIP½CaMKIIP1Km PP1½PP1; (15)
where Km_PP1 is the Michaelis constant for the PP1-CaMKII complex, and
kcat_PP1 is as determined in experiments (34).
The dissociation of CaMCa4 from CaMKIIP_CaMCa4 (rate C1) is cal-
culated in the same way as for A2. However, the dissociation rate constants
k_disso2 and k_dissoCa2 have a 1000-fold lower value compared to k_disso
and k_dissoCa, respectively, because autophosphorylated CaMKII shows a
1000-fold higher afﬁnity for CaMCa4 (19).











The transition from CaMKIIP to CaMKIIP_CaMCa4 (rate C2) is calculated
in the same way as A1:
C2 ¼ k asso3 ½CaMKIIP½CaMCa4: (17)
The time-dependent changes of individual CaMKII states are calculated as:
d½CaMKII CaMCa4=dt ¼ A1 A2 B11B2 (18)
d½CaMKIIP CaMCa4=dt ¼ B1 B2 C11C2 (19)
d½CaMKIIP=dt ¼ C1 C2 D1 (20)
½CaMKII ¼ ½CaMKIItotal  ½CaMKII CaMCa4
 ½CaMKIIP CaMCa4  ½CaMKIIP: (21)
All parameter values employed in the models are shown in Table 1. Some
parameters were chosen after ﬁtting the model to results of in vitro
experiments, as described below.
Since experimental data for the heart-predominant d isoform are limited, a
new kinetic model was ﬁrst constructed for the brain-speciﬁc a isoform of
CaMKII, for which experimental data obtained with different protocols are
available. Then the d isoform model was developed by modifying the pa-
rameter set of the a model according to the comparative experimental study
carried out on the four isoforms of CaMKII by Gaertner et al. (22).
All experimental data referred to in this article were obtained from rat or
mouse tissue. Since CaMKII shows a high sequence homology among
species (35), the assumption might be justiﬁed that the same kinetic scheme
and CaMKII activity are applicable to other species.
Generation of the Ca21 transient
The hypothetical Ca21 transient described by Negroni and Lascano (36) was
used to test the frequency-dependent activation of CaMKII. Ca21 release
from sarcoplasmic reticulum is given by Qrel and Ca
21 uptake by Qpump:
Qpump ¼ KP= 11 Km=½Ca21
 2 
(22)
Qrel ¼ Qmðt=tpÞ4e4ð1t=tpÞ1Qpumprest (23)
d½Ca21 =dt ¼ Qrel  Qpump: (24)
Kp (12 nM/ms) andKm (0.1mM) areQpump parameters.Qpumprest is aQpump at
a resting [Ca21] of 40 nM. Qm (60 nM/ms) is the peak Qrel, and tp (25 ms) is
the time at Qm.
The models were implemented in Java using the simBio package (37),
software for cell simulation. Differential equations are solved using a Euler
method with dynamically adjusted time steps.
Data analysis
To explore the degree of cooperativity in CaMKII activation, simulation results
shown in Figs. 2 and 5 were ﬁtted to the Hill equation (Eq. 25) by nonlinear
regression analysis using SigmaPlot (Version 10; SPSS, Chicago, IL)
A ¼ Amax½BnH= KnH0:51 ½BnH
 
; (25)
where A is the fraction of active CaMKII, with Amax expressing the maximum
value; B is either CaM, free CaMKII, or Ca21; K0.5 is [B] at half-maximum; and
nH is the slope of the relationship (Hill coefﬁcient). Fitted values are givenwith SE.
Since ﬁtting the CaMKIIamodel to different experimental conditions was
done manually, a meaningful parameter identiﬁability analysis could not be
applied. However, the simulation results were superimposed onto experi-
mental data to assess the appropriate parameter ﬁtting.
RESULTS
Analysis of CaMCa4 binding to CaMKIIa
The dependency of CaMKIIa activation on [CaMCa4] (steps
A1 and A2 of the model) was analyzed in the absence of
ATP, i.e., no autophosphorylation. Fig. 2 A shows the ex-
perimental results described by De Koninck et al. (38) (solid
circles) and Bradshaw et al. (34) (open squares), which were
obtained by ﬁxing the [Ca21] and [CaMKII] and measuring
the activation level of CaMKII in a quasi-steady state after
addition of different [CaM] in vitro. With the assumption of a




Sourcea isoform d isoform
[CaM]total 6 mM (12)
k1 2.5 mM
1 ms1 (16)










k_asso 2.1 mM1 ms1 Model ﬁt
k_disso 1.4 3 104 ms1 0.7 3 104 ms1 Model ﬁt
k_dissoCa 1.9 3 103 ms1 0.95 3 103 ms1 Model ﬁt
k_disso2 1.4 3 107 ms1 0.7 3 107 ms1 Model ﬁt
k_dissoCa2 1.9 3 106 ms1 0.95 3 106 ms1 Model ﬁt
KmCaM 3.0 3 105 mM (23)





kcat (at 30C) 3.0 3 104 ms1 1.8 3 103 ms1
kcat (at 37C) 9.0 3 104 ms1 5.4 3 103 ms1
KmATP 19.1 3 103 mM (22)
kcat_PP1 1.72 3 103 ms1 (34)
Km_PP1 11.0 3 103 mM (34)
Note that only kcat is temperature dependent.
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1:1 binding of CaMCa4 to CaMKII, i.e., nH ¼ 1.0, our
CaMKIIa model reconstructed well these experimental
results (Fig. 2 A, solid line). TheK0.5 (k_disso/k_asso) of 66.7
nM is within the range of various experimental K0.5 values,
such as 486 6 nM (34) and 796 8 nM (38) or the Kd value
for CaMCa4 binding (62.46 25.1 nM) (22). The assumption
of 1:1 binding, however, failed to simulate experimental
results obtained by Gaertner et al. (22) (Fig. 2 B), who applied
various [CaMKII]s to a solution containing ﬁxed [Ca21] and
[CaM], and plotted the CaM-bound fraction against free
[CaMKII]. Gaertner et al. (22) obtained a steeper slope with
nH ¼ 1.9 in their experiments, which they suggested was due
to a positive cooperativity in the binding of CaMCa4 to in-
dividual CaMKII molecules within the enzyme complex.
However, the noncooperative binding of CaMCa4 to CaMKII
is further supported by experimental data from Bradshaw
et al. (34), where the reaction of 0.2 mM CaMKII with 5 mM
CaM was measured after adding 1–100 mM [Ca21] for 1 min
(Fig. 2C, solid circles). Simulation data obtained by applying
the same experimental procedure yielded nH ¼ 2.98 6 0.03,
which is in line with the experimental data. This high coop-
erativity results from cooperative binding of Ca21 to CaM
(Fig. 2 C, solid line).
Reconstruction of experiments measuring the
CaMKIIa autophosphorylation rate
To examine the autophosphorylation rate, the dependency of
the autophosphorylation level on either [CaM] or [Ca21] was
analyzed in the presence of ATP. Fig. 3 shows a comparison
of experimental ﬁndings with simulation results. Since the
dephosphorylation step, B2 in the CaMKII model, is sup-
pressed in the absence of phosphatase activity, the phos-
phorylation level reached after a given activation time is
dependent on the overall autophosphorylation rate, which is
determined by steps A1, A2, and B1 in the model. The solid
line in Fig. 3 A indicates the sum of [CaMKIIP_CaMCa4] and
[CaMKIIP] obtained after a 15-s activation with different
[CaM] at 0C, according to the protocol by Gaertner et al.
(22). Fig. 3 B shows the reconstruction of an experiment as
performed by DeKoninck et al. (38), who measured the au-
tophosphorylated fraction after 6 s at 30C. Fig. 3 C shows
a comparison of the simulation results with data from an
experiment performed by Bradshaw et al. (34), who mea-
sured the autophosphorylation level 5 min after each applied
[Ca21] at 0C. The model parameters for the CaM-Ca21
binding, and k_asso, k_disso, and kcat match well all ex-
perimental data tested above. The steeper slope in the rela-
tionship in Fig. 3 C is caused by the cooperative binding of
Ca21 to CaM. The saturation of the relationships in Fig. 3 is
due to the saturation of the reaction rates of steps A and B at
higher [CaM] or [Ca21], and not to completion of auto-
phosphorylation. Thus, the saturation level is determined by
the duration of the activation time unique to each experi-
mental protocol. In the case of saturating high [Ca21], such as
FIGURE 2 Quasi-steady-state activation of CaMKIIa by CaM. Simula-
tions with the CaMKIIa model were carried out using in vitro experimental
protocols. Solid circles and open squares represent experimental data, and
solid lines the simulation results. (A) Experimental data are cited from
Bradshaw et al. (34) (squares) andDeKoninck and Shulman (38) (circles): In
the presence of 500 mMCa21, but the absence of ATP, 5 nM CaMKIIa was
incubated with different [CaM] (1–10,000 nM) for 1 min. The ratio of
[CaMKII_CaMCa4] to [CaMKII]total is plotted against [CaM]total (nH¼ 1.02;
K0.5¼ 69.856 0.02 nM). (B) Experimental data are cited fromGaertner et al.
(22): In the presence of 500mMCa21, but the absence of ATP, 100 nMCaM
was incubated with different [CaMKIIa] (1–10,000 nM) for 1 min. The ratio
of [CaMKII_CaMCa4] to [CaM]total is plotted against the free [CaMKII] (nH
¼ 1.00; K0.5 ¼ 67.46 6 0.00 nM). (C) Experimental data are cited from
Bradshaw et al. (34): In the absence of ATP and in the presence of different
[Ca21] (0.1–100 mM), 0.2 mM CaMKII was incubated with 5 mM CaM for
1 min. The ratio of [CaMKII_CaMCa4] to [CaMKII]total is plotted against
[Ca21]; (nH ¼ 2.986 0.03; K0.5 ¼ 3.466 0.01 mM).
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the 500 mM (KmCaM ¼ 30 nM) used in the experiments
shown in Fig. 3, A and B (Eq. 11), pathway 2 of step A2 is
almost completely blocked. It should be noted that the frac-
tion of CaMKIIP is a minor population in the sum of
[CaMKIIP_CaMCa4] and [CaMKIIP], because of the 1000-
fold smaller k_disso2 compared with k_disso.
Reconstruction of the frequency-dependent
activation of CaMKIIa
The frequency-dependent activation of CaMKIIa was dem-
onstrated by De Koninck et al. (38), who exposed CaMKII
molecules immobilized on a membrane to a phosphorylation
mixture containing Ca21, CaM, and ATP for a 200-ms du-
ration at 1.0, 2.5, and 4.0 Hz. The CaMKII autophosphor-
ylation level increased with time, as indicated in Fig. 4
(symbols), and the slope of this time-dependent increase
was markedly accelerated with increasing phosphorylation
frequency. As indicated by the solid lines in Fig. 4, the
CaMKIIa model satisfactorily reconstructed these experi-
mental data. During the time interval between the applica-
tions of the phosphorylation mixture, dissociation of
CaMCa4 from CaMKII_CaMCa4 proceeded mainly along
pathway 2 in the kinetic scheme in Fig. 1 B, in which Ca21
dissociates from CaMKII_CaMCa4 before the dissociation of
CaM (23). When the application interval was shortened, at
higher frequencies, the mean level of CaMKII_CaMCa4 in-
creased, which resulted in an accelerated accumulation of
phosphorylated species. If hypothetical pathway 2 was elim-
inated from reaction step A2, the dissociation of CaMCa4
from CaMKII_CaMCa4 through pathway 1 was too slow
during the stimulation interval, and the frequency depen-
dence of the CaMKII autophosphorylation observed over the
FIGURE 3 Relationship between the autophosphorylation level of
CaMKIIa and [CaM] or [Ca21]. Solid circles represent the experimental
data and solid lines the simulation results. (A) Experimental data are cited
from Gaertner et al. (22): In the presence of 0.1 mMATP and 500 mMCa21,
62 nMCaMKIIawas incubated with different [CaM] (1–10,000 nM) for 15 s
at 0C. The ratio of ([CaMKIIP] 1 [CaMKIIP_CaMCa4])/[CaMKII]total)
normalized to the maximum fraction is plotted against [CaM]total. (B)
Experimental data are cited from De Koninck and Shulman (38). In the
presence of 0.25 mMATP and 500 mMCa21, 5 nM CaMKIIa was incubated
with different [CaM] (1–10,000nM) for 6 s at 30C.The ratio of ([CaMKIIP]1
[CaMKIIP_CaMCa4])/[CaMKII]total) is plotted against [CaM]total. (C) Exper-
imental data are cited fromBradshaw et al. (34): In the presence of 2 mMATP
and different [Ca21] (0.1–100 mM), 0.2 mM CaMKII was incubated with
50 mM CaM for 5 min at 0C. The percentage of the autophosphorylated
CaMKII fraction is plotted against [Ca21]. Different values of kcatwere used
for the simulations to adjust the temperature (see Table 1).
FIGURE 4 Frequency-dependent activation of CaMKIIa. Experimental
data are cited from reference (38). The phosphorylation mixture (500 mM
Ca21, 100 nM CaM, and 0.25 mM ATP) was applied to CaMKIIa for 200
ms at different frequencies; solid squares, open triangles, and solid circles
represent 1, 2.5, and 4 Hz, respectively. During the interval of applying the
phosphorylation mixture, [Ca21] was set at zero. Solid lines represent the
simulation results.
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range of ;1–4 Hz was highly reduced (data not shown). It
should be noted that the involvement of pathway 2 is negli-
gibly small under the experimental conditions used in Fig. 3,
but becomes a major route when [Ca21] is low compared to
the KmCaM of 30 nM (23) (see Eq. 11). The fact that Ca21
was chelated using EGTA during the intervals in experiments
by De Koninck et al. (38) validates the addition of pathway 2
in our model.
Parameter determination for the CaMKIId model
Gaertner et al. (22) found that the CaMKIId isoform exhibited
a higher CaM afﬁnity, speciﬁcally,Kd¼ 33.5 nM versusKd¼
62.4 nM, and a faster autophosphorylation compared to the
CaMKIIa isoform. To convert the CaMKIIa model to a
CaMKIId model with a minimum of modiﬁcations, the rate
constants k_disso, k_dissoCa, k_disso2, and k_dissoCa2
were decreased twofold and kcat was increased sixfold. Fig.
5 A, which corresponds to Fig. 2 B for the CaMKIIa isoform,
compares the simulation results (solid line) with experimental
data (ﬁlled circles) obtained with the CaMKIId isoform
for the quasi-steady-state relationship between the free
[CaMKII] and the CaMCa4 bound fraction, [CaMKII_
CaMCa4]. Fig. 5 B represents the autophosphorylation level
of CaMKIId accumulated after a 15-s application of different
[CaM] (1–10,000 nM) at 0C in the presence of 0.1 mMATP
and 500 mM Ca21, corresponding to Fig. 3 A, which shows
the same relationship for CaMKIIa. The CaMKIId model
obtained after the above-described changes of only ﬁve rate
constants well matches experimental ﬁndings.
Cumulative activation of CaMKIId by
repetitive Ca21-transients
For the reconstructions of the experimental ﬁndings de-
scribed above (Figs. 2–5), Ca21 was either applied continu-
ously or as repetitive 200-ms pulses. However, to investigate
the potential role of CaMKII phosphorylation in the FDAR
(3,5,13,14), it is important to use the ‘‘physiological’’ myo-
cyte Ca21 transient. The upper panels in Fig. 6 A show the
cardiac Ca21 transient (36), which was applied in the ex-
amination of the cumulative CaMKII activation as shown in
Fig. 6 B. First, the time courses of [CaMCa2] and [CaMCa4]
were calculated at stimulus frequencies of 3 and 5 Hz to
examine whether active CaM accumulates with increasing
stimulus frequency due to the slow dissociation of Ca21 from
the C-terminal lobe. As illustrated in the lower panels of Fig.
6 A, accumulation of active CaM is absent at 3 Hz, but a slight
accumulation was detected at 5 Hz. This accumulation is due
to a slight overlap of the Ca21 tail with the next Ca21 tran-
sient. On the contrary, the cumulative activation of CaMKII
occurred progressively even at a stimulus frequency of 0.5Hz
(Fig. 6B, left panel). The rapid rise of the [CaMKII_CaMCa4]
with a rise in the [Ca21] was followed by a relatively slow
decay during each stimulus cycle. The phosphorylated frac-
tion ([CaMKIIP_CaMCa4]) increased steadily with time,
eventually to 100%, since no phosphatase activity was pro-
vided in this simulation. Due to the slow relaxation during
‘‘diastole’’, the rate of [CaMKII_CaMCa4] increase was
markedly enhanced at the higher stimulus frequency of 3 Hz
(Fig. 6 B, right panel). With time the [CaMKIIP_CaMCa4]
markedly increased at the expense of the [CaMKII_CaMCa4].
It is suggested that the cumulative activation of CaMKIId is
not attributable to the Ca21 binding to CaM, but to the
CaMKIId kinetics over the physiological range of the heart
rate.
Regulation of activated CaMKIId
through phosphatases
In vivo dephosphorylation by PPs affects the frequency-de-
pendent activation of CaMKII. We ﬁrst examined whether
our CaMKIIa model could reproduce experimental data
obtained for the neuronal CaMKIIa. The steady-state level of
autophosphorylation was measured by Bradshaw et al. (34).
FIGURE 5 (A) Steady-state binding of CaM to CaMKIId and (B)
CaMKIId autophosphorylation after a given activation time with [CaM].
Solid circles represent experimental data and solid lines the simulation
results. Experimental data are cited from Gaertner et al. (22). (A) Experi-
mental conditions used for the simulation are the same as described in Fig.
2 B; (nH ¼ 1.0; K0.5 ¼ 33.776 0.03 nM). (B) Experimental conditions used
for the simulation are the same as those described in Fig. 3 A.
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The experimental ﬁndings are shown in Fig. 7 in comparison
with simulation results obtained with essentially the same
experimental protocol used in Fig. 3 C, but in the presence of
1.25 mM of PP1. The experimentally determined values of
kcat_PP1 and Km_PP1 inserted in this CaMKIIa model
could well reproduce these experimental data (34). Due to the
lack of experimental data for the d isoform, the same
pair—kcat_PP1 and Km_PP1—was used in the CaMKIId
model to calculate this relation (Fig. 7, red line). The ob-
served leftward shift of the [Ca21] dependency is due to the
higher rates in A2 and B1, which were validated in Fig. 5.
In Fig. 8 A, the inﬂuence of PP1 on the frequency-de-
pendent activation of CaMKIId was examined. To our
knowledge, however, the cellular concentration of PPs has
not been precisely measured, and region-speciﬁc variations
in PP expression were found in the human heart (33).
Therefore, we examined the opposing inﬂuence of PP1 on the
autophosphorylation of CaMKII by systematically changing
the [PP1] from 0.01 to 3 mM in the simulations. The steady-
state values of the activated fraction, given by ([CaMKII]total –
[CaMKII])/[CaMKII]total, are plotted against the frequency
(Fig. 8 A). At a low [PP1] of 0.01 mM, the activated fraction
of CaMKIId is highly frequency-dependent, ranging from
14% at 0.5 Hz to 96% at 5 Hz, displaying a hyperbolic re-
lationship. With increasing [PP1], the activation-frequency
curve changes to a sigmoidal shape over the medium range of
[PP1] and to an exponential relation for high phosphatase
levels. At a [PP1] of 3 mM, CaMKIId autophosphorylation
was almost completely suppressed.
To demonstrate functional differences between the CaMKII
isoforms, the same simulation protocol was applied to the
CaMKIIamodel. As shown in Fig. 8 B, CaMKIIa activation
was much more sensitive to [PP1]. A [PP1] of 0.1 mM could
almost suppress the activation. These results are due to the
lower afﬁnity of CaMKIIa for CaM and its slower auto-
phosphorylation rate.
The relationship shown in Fig. 8 A suggests a role of PPs in
the dynamic adjustment of CaMKIId activity over the
physiological range of the heart rate. For example, in guinea
pig heart, with a physiological frequency range of 3–6 Hz, a
[PP1] of 0.1–0.3 mMmight play a role, whereas in the human
heart, with a rate of 1–3 Hz, a much lower [PP1] of 0.01–0.03
mM might be appropriate.
DISCUSSION
To clarify the dynamic regulation of the CaMKII activation,
especially through variation of both the heart rate and the
FIGURE 6 Cumulative activation of
CaMKIId by Ca21 transients in the ab-
sence of PPs. (A) Time courses for
[CaMCa2] (lower panels, black lines)
and [CaMCa4] (red lines) evoked by
applying the Ca21 transient of Negroni
and Lascano (36) indicated in the upper
panel at stimulus frequencies of 3Hz (left
panel) and 5 Hz (right panel). Stimula-
tion was started at time zero after a long
pause. (B) Simulation results obtained
with the CaMKIId model activated with
the Ca21 transient at 0.5 Hz (left panel)
or 3 Hz (right panel) at 37C. Concen-
trations used are 5 mM [ATP], 6 mM
[CaM], and 0.1 mM [CaMKIId]. Upper
panels depict the Ca21 transients, and
lower panels show the time-dependent
changes of theCaMKII_CaMCa4 fraction
(black lines) and the CaMKIIP_CaMCa4
fraction (red lines). The changes in the
CaMKIIP fraction were too small to be
detected in these graphs.
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concentration of PPs, a novel and simple four-state CaMKIId
model was developed that includes autophosphorylation and
dephosphorylation by PP1. Although several cardiac CaMKII
models were reported, they were not directly ﬁtted to ex-
perimental data of the d isoform (20,21) or did not include the
deactivation of CaMKII by dephosphorylation (22). Both
models, CaMKIIa and CaMKIId, used in this study could
well reproduce experimental ﬁndings regarding the steady-
state dose-response relationships for activation by CaMCa4
(Figs. 2 and 5 A), and the time-dependent accumulation of
activated CaMKII fraction (Figs. 3 and 5 B). Simulations for
the frequency-dependent activation of CaMKIIa induced
by a repetitive pulse-like application of the phosphorylation
mixture interrupted by a Ca21-free medium strongly supports
the existence of pathway 2 of step A2 in the kinetic scheme
(Fig. 1), where Ca21 dissociates before CaM from CaMCa4-
bound CaMKII. The PP1 regulation of the frequency-de-
pendent accumulation of activated CaMKII was clariﬁed. In
particular, PP1 within a physiological concentration range
(0.01–0.1 mM) provides a dynamic way to regulate the fre-
quency-dependent activation of CaMKIId, and the heart rate
variations are well covered. Our simulation results suggest
that different phosphatase activities might be involved in
frequency-dependent regulation of CaMKII activity, adjust-
ing the activation level of CaMKII to the various physio-
logical heart rates found for different species.
Signiﬁcance of CaMKII autophosphorylation in
the cardiac FDAR
Total concentrations of CaM, PP1, and CaMKII greatly
affect simulation results, as exempliﬁed by varying the
concentration of PP1 in Fig. 8. In this study, protein con-
centrations were chosen that represent the level expected for
cardiac myocytes. A [CaM]total of 6mM is in accordance with
an experimental measurement in cardiac myocytes (12). Al-
though it is difﬁcult to directly measure [PP1] and [CaMKII]
in experiments, we estimated a [PP1] based on experimental
values of PP1 activity/total cellular protein, Ap, of 1.07 units/
mg (39), and protein concentration, [P]cell, of 37.5 mg/ml
(40) measured in cardiac myocytes. Using a PP1-speciﬁc
activity, As, of 13,300 units/mg and the PP1molecular weight






The [CaMKII] was determined, in the same way used for
[PP1], to be 0.12 mM, using CaMKII activity of 4 units/mg
measured in cardiac myocytes (41), the same protein con-
centration as above (40), a CaMKII speciﬁc activity of
21,100 units/mg, and a CaMKII molecular weight of 58,000.
FIGURE 7 Ca21-mediated activation of CaMKIIa and CaMKIId in the
presence of PP1. Solid circles represent experimental data and solid lines the
simulation results for CaMKIIa (black) and CaMKIId (red). Experimental
data are cited from Bradshaw et al. (34). In the presence of 2 mM ATP and
different [Ca21] (0.1–100 mM), 1 mM CaMKII and 1.25 mM PP1 were in-
cubated with 5 mM CaM at 0C. The steady-state value of the auto-
phosphorylated CaMKII fraction is plotted against [Ca21].
FIGURE 8 Effects of [PP1] variation on the frequency-dependent activa-
tion of CaMKII. The cardiac Ca21 transient, shown in Fig. 6 A was applied
at different frequencies (0.5, 1, 2, 3, 4, and 5 Hz) to the CaMKIId (A) and the
CaMKIIamodel (B). The steady-state values of ([CaMKII]total – [CaMKII])/
[CaMKII]total are plotted against the frequency of the Ca
21 transient. The
simulations were performed in the presence of 5 mM ATP, 6 mM CaM, and
a total [CaMKII] of 0.1 mM for different [PP1] (0, 0.01, 0.03, 0.1, 0.3, 1, and
3 mM) at 37C.
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The combination of 0.1 mM [CaMKII], 0.1 mM [PP1], and
6 mM [CaM]total in Fig. 8 A well reconciled the apparent
dissociation of FDAR and protein phosphorylation by
CaMKII suggested by Huke and Bers (14). They found no
change in the amount of phosphorylated CaMKII after 2-Hz
pacing for 5 min in rat cardiac myocytes. A rise of CaMKII
autophosphorylation was observed only after a strong inhi-
bition of PP1 at the 2-Hz pacing. They suggested that
CaMKII has no role in FDAR. Our simulation results, pre-
sented in Fig. 8, are in roughly good agreement with their
experimental results. In particular, in the presence of a
physiological [PP1] of 0.1 mM, the fraction of activated
CaMKII is negligibly small at 2-Hz stimulation, but gains
signiﬁcance progressively with decreasing PP1 activity,
which would correspond to an experimental blocking of PPs.
However, it is interesting to note that the simulation predicts
that CaMKII is indeed a feasible candidate for regulating
FDAR over the physiological heart rate (;240–400 min1,
or 4–7 Hz) in rat heart. At these higher frequencies, dynamic
changes in the autophosphorylation of CaMKII are apparent
in Fig. 8 even at high [PP1] such as 1 mM. We conclude
that CaMKII is capable of mediating cardiac FDAR, with
CaMKII autophosphorylation playing a role.
Functional differences between CaMKIIa
and CaMKIId
The structural and enzymatic differences among the a, b, g,
and d CaMKII isoforms were extensively studied in vitro,
and their differences were reported to be small (22). How-
ever, it was suggested that subtle changes among these iso-
forms might result in drastic differences in the activation
dynamics under various cellular environments (22). For
converting the a isoform model to the CaMKIIdmodel based
on experimental data, a twofold decrease in the CaM afﬁnity
and a sixfold increase in the autophosphorylation rate were
required. To estimate the physiological impact of these dif-
ferences, simulations were performed with bothmodels using
the same cardiac myocyte speciﬁc Ca21 transient only for
comparison, although neuronal Ca21 transients are different
(16) in both time course and peak magnitude from Ca21
transients in cardiac myocytes. According to our simulation
results (Fig. 8 B), CaMKIIa autophosphorylation was sup-
pressed at all frequencies tested by a [PP1] of 0.1 mM, which
is close to our estimated cellular [PP1] in cardiac myocytes.
This is in strong contrast to the results in Fig. 8 A, where
CaMKIId was strongly activated at higher frequencies.
CaMKIIa is accumulated at the postsynaptic density in
neurons and involved in long-term potentiation, which is
induced by high stimulation frequencies (;30 Hz) (8,9,41).
Therefore, lower frequencies, such as 5 Hz, used in the preent
simulations described here do not seem sufﬁcient to activate
CaMKIIa, especially in the presence of PPs. This clearly
shows that CaMKII isoforms are adapted to meet the con-
ditions in their respective cellular environment.
Model limitations
As our proposed model is a simple one, it exhibits limita-
tions. For all three active states considered in the model
(CaMKII_CaMCa4, CaMKIIP_CaMCa4, and CaMKIIP) the
same autophosphorylation activity was assumed. This is
different than the general assumption that some CaMKII
states exhibit only partial activity, in particular, CaMKIIP
(19). However, since the fraction of CaMKIIP is quite small
compared to those of the other two active states, a variation of
the autophosphorylation activity for different states might not
remarkably inﬂuence our conclusions. Moreover, CaMKIIa
autophosphorylated at Thr286 was shown to undergo further
autophosphorylation at Thr305/Thr306 after dissociation of
CaM, known as secondary or inhibitory autophosphory-
lation. In this state, sometimes called the capped state (19),
CaMKII still exhibits some autonomous activity, but it can-
not regain full activity through CaMCa4 binding since these
threonine residues reside in the CaM binding site. It has been
reported that inhibitory autophosphorylation plays an im-
portant role in synaptic metaplasticity (42). Since, to our
knowledge, it is not known whether secondary autophos-
phorylation occurs in cardiac myocytes, a capped state was
not considered in our model.
Experimental data for the kinetic properties of CaMKIId
are still very limited. Therefore, our model may have to be
modiﬁed in the future according to newly obtained experi-
mental results, especially concerning the localization of
CaM, PPs, and CaMKII molecules within the cell, as well as
their local concentrations. In this study, [PP1] and [CaMKII]
were estimated based on average, probably cytoplasmic,
concentrations within the cell (Eq. 26). Any variation in the
Ca21 afﬁnity of the N-terminal lobe of CaM largely affects
reaction step A1 by varying the [CaMCa4] (Fig. 1). Kd
measurements for Ca21 binding to the N-terminal lobe of
CaM are variable, ranging from 2.6 to 13 mM depending on
experimental conditions (12,23,24). It should be noted that
the simulation study presented here is useful in designing
new experimental studies despite the above-stated limitations
of the model.
Importance of CaMKII-PP1 regulation in
heart disease
Although CaMKII autophosphorylation might be insigniﬁ-
cant in the normal heart, due to strong control by phospha-
tases, an almost threefold increase in CaMKII activity was
found in patients with end-stage dilated cardiomyopathy
(43). Furthermore, in mice in which pressure overload was
induced by aortic constriction, Zhang et al. found that the
expression of CaMKIIdC was upregulated and the kinase
activity was increased due to autophosphorylation (44). The
same group found, in addition, that transgenic mice over-
expressing CaMKIIdC developed a dilated cardiomyopathy.
In an immunoprecipitation compared to wild-type mice, a
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greater amount of the enzyme was associated with the ry-
anodine receptor, a CaMKII target, resulting in a high
phosphorylation of the receptor and, subsequently, a strongly
altered Ca21 homeostasis (45), whereas PP1 and PP2A
protein levels were unaltered (44). Moreover, in transgenic
mice overexpressing the phosphatase calcineurin which re-
sulted in a severe cardiomyopathy, CaMKII activity was also
found to be increased (46). The above experimental ﬁndings
clearly show that in cardiac myocytes, CaMKII and its PPs
need to be highly regulated, and that a tiny disturbance of this
balance could result in heart disease. Future work will in-
corporate the CaMKIId model presented here in a compre-
hensive cardiac myocyte model to analyze these complex
mechanisms.
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